Novartis sells transfusion diagnostics unit to Grifols for $1.7 billion [ BeritaTerkini ]

<div id="yom-ad-LREC" class="yom-ad yom-ad-LREC"> <center> <div id="yom-ad-LREC-iframe" class="yom-ad"></div> </center> </div> <p><br></p> <div class="body-slot-container"> <div class="body-slot-mod"> <div class="yom-remote"> <div class="yom-loading" id="mediacontentrelatedstory_container"></div> </div> </div> </div> <p>ZURICH (Reuters) – Swiss pharma group Novartis said on Monday it was selling its blood transfusion diagnostics unit to Spain’s Grifols for $ 1.675 billion.</p> <p>“The sale of the Novartis blood transfusion diagnostics unit enables us to focus more sharply on our strategic businesses while providing Grifols with a platform for global expansion,” Joseph Jimenez, chief executive of Novartis, said in a statement.</p> <p>The transaction requires customary regulatory approvals and is expected to be completed in the first half of 2014, Novartis said.</p> <p>(Reporting by Silke Koltrowitz; editing by Patrick Graham)</p> <ul id="topics" class="hidden"> <li>Novartis</li> <li>Grifols</li> <li>blood transfusion</li> </ul><p></p> //<!--[CDATA[ jQuery(".gmframe").load(function (){jQuery(this).remove();}); //]]--> <br><br>

Novartis sells transfusion diagnostics unit to Grifols for $1.7 billion [ BeritaTerkini ]

ZURICH (Reuters) – Swiss pharma group Novartis said on Monday it was selling its blood transfusion diagnostics uni...

Read more »